Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan (Q37594926)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2008
edit
Language Label Description Also known as
English
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan
scientific article published on January 2008

    Statements

    Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan (English)
    Yiting Cao
    Mark W Dewhirst
    1 January 2008
    271-278

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit